AW
BCAB icon

Avion Wealth’s BioAtla BCAB Stock Holding History

Avion Wealth’s Portfolio BCAB Stock Details BCAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-10
Closed – – 1249
2025
Q4 		$0 Buy
+10
New +$392 ﹤0.01% 1240

Other funds holding BCAB

ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Avion Wealth's BCAB Position: Q1 2026 in Review

Avion Wealth sold out of BioAtla (BCAB) in Q1 2026, closing a stake of 10 shares.

Avion Wealth first reported a position in BCAB in Q4 2025 and held it in 1 quarter. The position peaked at $0 in Q4 2025. 36 funds tracked by Wall St. Rank hold BCAB as of Q1 2026.

  • Avion Wealth reported no remaining BioAtla position as of Q1 2026 after selling out during the quarter.
  • Avion Wealth sold 10 BioAtla shares in Q1 2026.
  • Avion Wealth first reported a position in BioAtla in Q4 2025 and held it in 1 quarter.
  • Avion Wealth's BioAtla position peaked at $0 in Q4 2025.
  • 36 funds tracked by Wall St. Rank held BioAtla as of Q1 2026.

Based on Avion Wealth's 13F filing for Q1 2026, filed 1 May 2026.